Medscape Infectious Disease Podcast

New guidelines from IDSA/SHEA highlight best practices for treating C difficile infection. Dr David Johnson provides insight for all providers who must be cognizant of this widespread problem.

Dr Paul Sax reports on a new recommended HIV treatment option and thanks Marty Hirsch for his skillful leadership of the guidelines working group.

Children with autism, and their younger siblings, have lower vaccination rates than other children, placing them at risk for vaccine-preventable disease.

Dr Paul Sax reports on an intriguing two-drug regimen that could become the standard of care in preventing TB.

Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine.

Dr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.

The media reports of influenza-related deaths in children are frightening. How does this year compare with prior years?

Dr Paul Offit compares Shingrix with Zostavax® and lays out the recommendations for the new vaccine.

As the 2017-18 flu season rages on, experts discuss the best ways to help vulnerable patients.

Dr Paul Offit explains the various ways the flu virus can mutate away from the strains in the vaccine, as it has in the 2017-2018 season.